Strategic Acquisition Agrivida was acquired by Novus International in January 2023, indicating a strong alignment with animal health and nutrition players. This suggests sales opportunities for expanded in-grain enzyme solutions and potential cross-sell of INTERIUS-based capabilities to Novus’ existing customer base.

In-Grain Advantage GRAINZYME Phytase is produced directly inside animal feed, reducing the need for external enzyme additives. This unique value prop presents a compelling upsell path to livestock producers seeking lower feed costs, reduced waste, and a smaller environmental footprint.

Funding & Growth With substantial funding and a named revenue range, Agrivida demonstrates financial viability and investment momentum. Opportunities exist to approach allied agribusinesses and feed formulators looking to co-develop or license existing technology to accelerate market adoption.

Partnership Heritage Long-standing collaboration with Novus International since 2021 underscores a proven partnership model. Leverage this track record to pitch expanded research collaborations, joint development of next-generation enzymes, and broader distribution agreements.

Recognition Signals Recognition as a top impact company and ongoing technology development, including INTERIUS, signals a forward-looking portfolio. Target sustainability-focused feed manufacturers and certification-driven buyers seeking high-ROA, reduced environmental impact, and robust ESG credentials.